Sun Pharma Q3 results: The company's consolidated profit after tax came at Rs 2,523.75 crore for the quarter ended December 31, 2023, as against Rs 2,166.01 crore in the same period last fiscal.
The stock has rallied nearly 40% from its 52-week low of Rs 922.45, the stock hit in May, this year. Its one-year returns stand at 27% which is higher than 16% returns given by broader Nifty during this period while lower than the Nifty Pharma index which has given over 29% returns.
Sun Pharma share price: Global research and broking firm Jefferies maintained its 'Buy' rating on the stock with a revised target of Rs 1,150 per share from Rs 1,200 earlier. The brokerage sees Sun Pharma as the best long-term story in the pharma space.
Hot stocks today: Benchmark stock indices on Monday opened higher as Q4 earnings continue to pour in for corporate India. Shares of Reliance Industries were flat in early trade. Nykaa, Sun Pharma, Wipro, Bajaj Auto, Mirza International among hot stocks on April 24, 2023.